These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 9420633

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A novel inotropic vasodilator, OPC-18790, reduces myocardial oxygen consumption and improves mechanical efficiency with congestive heart failure.
    Kanda H, Yokota M, Ishihara H, Nagata K, Kato R, Sobue T.
    Am Heart J; 1996 Aug; 132(2 Pt 1):361-8. PubMed ID: 8701899
    [Abstract] [Full Text] [Related]

  • 3. Effects of a novel inotropic agent (OPC-18790) on systolic and diastolic function in patients with severe heart failure.
    Hoit BD, Burwig S, Eppert D, Bhat G, Walsh RA.
    Am Heart J; 1994 Dec; 128(6 Pt 1):1156-63. PubMed ID: 7985596
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A randomized comparison of intravenous amrinone versus dobutamine in older patients with decompensated congestive heart failure.
    Rich MW, Woods WL, Davila-Roman VG, Morello PJ, Kurz H, Barbarash R, Spinner L, Sperry J, Beckham V, Coulter L.
    J Am Geriatr Soc; 1995 Mar; 43(3):271-4. PubMed ID: 7884117
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.
    Metra M, Nodari S, D'Aloia A, Muneretto C, Robertson AD, Bristow MR, Dei Cas L.
    J Am Coll Cardiol; 2002 Oct 02; 40(7):1248-58. PubMed ID: 12383572
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of prostaglandin E1, dobutamine and placebo on hemodynamic, renal and neurohumoral variables in patients with advanced heart failure.
    Wimmer A, Stanek B, Kubecova L, Vitovec J, Spinar J, Yilmaz N, Kos T, Hartter E, Frey B, Pacher R.
    Jpn Heart J; 1999 May 02; 40(3):321-34. PubMed ID: 10506854
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Colucci WS, Wright RF, Jaski BE, Fifer MA, Braunwald E.
    Circulation; 1986 Mar 02; 73(3 Pt 2):III175-83. PubMed ID: 3510774
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Additive effects of milrinone and dobutamine in severe heart failure].
    Meissner A, Herrmann G, Gerdesmeyer L, Simon R.
    Z Kardiol; 1992 May 02; 81(5):266-71. PubMed ID: 1621407
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hemodynamic response of a canine model of chronic heart failure to intravenous dobutamine, nitroprusside, enalaprilat, and digoxin.
    Sabbah HN, Levine TB, Gheorghiade M, Kono T, Goldstein S.
    Cardiovasc Drugs Ther; 1993 Jun 02; 7(3):349-56. PubMed ID: 8395876
    [Abstract] [Full Text] [Related]

  • 18. Beneficial cumulative role of both nitroglycerin and dobutamine on right ventricular systolic function in congestive heart failure patients awaiting heart transplantation.
    Juillière Y, Feldmann L, Perrin O, Berder V, Danchin N, Cherrier F.
    Int J Cardiol; 1995 Nov 10; 52(1):17-22. PubMed ID: 8707430
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.